Coherus Fends Off Amgen’s Pegfilgrastim Purification Patent Case

 
• By Aidan Fry
  
Chromatography
Coherus' chromatography steps for purifying pegfilgrastim do not infringe Amgen's US patent, the US Court of Appeals has confirmed • Source: Shutterstock

More from Biosimilars

More from Products